Angelos Angelakas

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Csilla Várnai, Claire Palles, Roland Arnold et al. · JAMA Network Open · 2022 · 58 citations · Full text

Medicine, Infectious Diseases, Oncology +14

The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.

Anna Olsson‐Brown, Mark Baxter, Laura Feeney et al. · Journal of Clinical Oncology · 2022 · 23 citations

Life Sciences, Immunology, Oncology +15

Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome

Rebecca Lee, Oskar Wysocki, Talvinder Bhogal et al. · ESMO Open · 2021 · 21 citations · Full text

Medicine, Clinical Sciences, Oncology +9

Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital

Rebecca Lee, Oskar Wysocki, Cong Zhou et al. · JCO Clinical Cancer Informatics · 2022 · 12 citations · Full text

Computing, Oncology, Cancer Screening +16